Acute Cerebrovascular Accidents
|
0.360 |
Therapeutic
|
disease |
CTD_human |
Local low dose intra-arterial thrombolytic therapy: the risk of stroke or major haemorrhage.
|
2514002 |
1989 |
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
Local low dose intra-arterial thrombolytic therapy: the risk of stroke or major haemorrhage.
|
2514002 |
1989 |
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
An open, multicenter trial of recombinant tissue plasminogen activator in acute stroke. A progress report. The rt-PA Acute Stroke Study Group.
|
2124386 |
1990 |
Acute Cerebrovascular Accidents
|
0.360 |
Therapeutic
|
disease |
CTD_human |
An open, multicenter trial of recombinant tissue plasminogen activator in acute stroke. A progress report. The rt-PA Acute Stroke Study Group.
|
2124386 |
1990 |
Acute Cerebrovascular Accidents
|
0.360 |
Therapeutic
|
disease |
CTD_human |
The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico II (GISSI-2), and The International Study Group.
|
1598096 |
1992 |
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico II (GISSI-2), and The International Study Group.
|
1598096 |
1992 |
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
An overview of the patency and stroke rates following thrombolysis with streptokinase, alteplase, and anistreplase used to treat an acute myocardial infarction.
|
10171637 |
1993 |
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. The rt-PA Acute Stroke Study Group.
|
8427107 |
1993 |
Acute Cerebrovascular Accidents
|
0.360 |
Therapeutic
|
disease |
CTD_human |
Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. The rt-PA Acute Stroke Study Group.
|
8427107 |
1993 |
Acute Cerebrovascular Accidents
|
0.360 |
Therapeutic
|
disease |
CTD_human |
An overview of the patency and stroke rates following thrombolysis with streptokinase, alteplase, and anistreplase used to treat an acute myocardial infarction.
|
10171637 |
1993 |
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
Tissue plasminogen activator for acute ischemic stroke.
|
7477192 |
1995 |
Acute Cerebrovascular Accidents
|
0.360 |
Therapeutic
|
disease |
CTD_human |
Tissue plasminogen activator for acute ischemic stroke.
|
7477192 |
1995 |
Acute Cerebrovascular Accidents
|
0.360 |
Therapeutic
|
disease |
CTD_human |
Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
|
8598594 |
1996 |
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
|
8598594 |
1996 |
Acute Cerebrovascular Accidents
|
0.360 |
Therapeutic
|
disease |
CTD_human |
A systems approach to immediate evaluation and management of hyperacute stroke. Experience at eight centers and implications for community practice and patient care. The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group.
|
9259745 |
1997 |
Acute Cerebrovascular Accidents
|
0.360 |
Therapeutic
|
disease |
CTD_human |
Variables associated with hospital arrival time after stroke: effect of delay on the clinical efficiency of early treatment.
|
9056608 |
1997 |
Acute Cerebrovascular Accidents
|
0.360 |
Therapeutic
|
disease |
CTD_human |
Nursing management of acute complications following rt-PA in acute ischemic stroke. The NINDS rt-PA Stroke Study Group.
|
9479658 |
1997 |
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
Code Stroke: rapid transport, triage and treatment using rt-PA therapy. The NINDS rt-PA Stroke Study Group.
|
9479657 |
1997 |
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
A systems approach to immediate evaluation and management of hyperacute stroke. Experience at eight centers and implications for community practice and patient care. The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group.
|
9259745 |
1997 |
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
Nursing management of acute complications following rt-PA in acute ischemic stroke. The NINDS rt-PA Stroke Study Group.
|
9479658 |
1997 |
Acute Cerebrovascular Accidents
|
0.360 |
Therapeutic
|
disease |
CTD_human |
Code Stroke: rapid transport, triage and treatment using rt-PA therapy. The NINDS rt-PA Stroke Study Group.
|
9479657 |
1997 |
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
Variables associated with hospital arrival time after stroke: effect of delay on the clinical efficiency of early treatment.
|
9056608 |
1997 |
Acute Cerebrovascular Accidents
|
0.360 |
Therapeutic
|
disease |
CTD_human |
Total quality improvement method for reduction of delays between emergency department admission and treatment of acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.
|
9400355 |
1997 |
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
Total quality improvement method for reduction of delays between emergency department admission and treatment of acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.
|
9400355 |
1997 |
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
tPA-associated reperfusion after acute stroke demonstrated by SPECT.
|
9472885 |
1998 |